A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses.


Updates from The Motley Fool

Latest updates on PDL BioPharma from Fool.com.  The Fool has written over 200 articles on PDL BioPharma.
3 Terrible Stocks for Retirees

Image source: Getty Images. For those of you who've reached retirement, let me offer my congratul...

3 Horrible Stocks for Retirees

Image source: Getty In today's low-interest-rate environment, many retirees are turning to the st...

3 Tempting Stocks to Avoid

Sometimes it's difficult to distinguish between a value trap and a value buy. Some stocks can loo...

3 Big Risks Biotech Stocks Face

Biotech is a notoriously risky sector. What seems like a sure success one day can easily result i...



Stock Performance

View Interactive PDLI Charts
Sponsored by

Key Data Points

Primary metrics and data points about PDL BioPharma.
Current Price: $2.10
Prev Close: $2.21
Open: $2.19
Bid: $2.09
Ask: $2.24
Day's Range: $2.06 - $2.24
52wk Range: $2.06 - $3.95
Volume: 3,278,807
Avg Vol 2,902,128
Market Cap: $344M
P/E (ttm): 2.07
EPS (ttm): $1.07
Div & Yield: $0.60 (0.0%)

Company Rating

What our community thinks about PDL BioPharma.
CAPS Rating 3 out of 5
 
841 Outperform
47 Underperform
CAPS All Stars
 
173 Outperform
12 Underperform

How do you think PDL BioPharma will perform against the market?



You pick for PDL BioPharma is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John P. McLaughlin, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for PDL BioPharma.

A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers